Epinephrine
ApprovedRecruiting 0 views this week 0 watching⚡ Active
Interest: 50/100
50
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cardiac Arrest, Out-Of-Hospital
Conditions
Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation, Ventricular Tachycardia-Pulseless
Trial Timeline
May 24, 2023 → Dec 1, 2028
NCT ID
NCT03826524About Epinephrine
Epinephrine is a approved stage product being developed by Pfizer for Cardiac Arrest, Out-Of-Hospital. The current trial status is recruiting. This product is registered under clinical trial identifier NCT03826524. Target conditions include Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation.
What happened to similar drugs?
4 of 14 similar drugs in Cardiac Arrest, Out-Of-Hospital were approved
Approved (4) Terminated (3) Active (8)
Hype Score Breakdown
Clinical
20
Activity
15
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03826524 | Approved | Recruiting |
Competing Products
20 competing products in Cardiac Arrest, Out-Of-Hospital